In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates

MLA

Atilio Reyes-Romero, et al. “In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.” Molecules (Basel, Switzerland), vol. 26, no. 7, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....295badc99cedf61988dddbcfdcb66311&authtype=sso&custid=ns315887.

APA

Atilio Reyes-Romero, Angel J Ruiz-Moreno, Marco A. Velasco-Velázquez, & Alexander Dömling. (2021). In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates. Molecules (Basel, Switzerland), 26(7).

Chicago

Atilio Reyes-Romero, Angel J Ruiz-Moreno, Marco A. Velasco-Velázquez, and Alexander Dömling. 2021. “In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.” Molecules (Basel, Switzerland) 26 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....295badc99cedf61988dddbcfdcb66311&authtype=sso&custid=ns315887.